Mian Khalid

Icahn School of Medicine at Mount Sinai

Papers

1

Total Citations

10

H-Index

1

About

Mian Khalid is a leading voice in head and neck surgical oncology, with a focused expertise in the treatment of human papillomavirus-related oropharyngeal cancer (HPV+OPC). His major contribution lies in the critical evaluation and validation of cancer staging systems for patients undergoing minimally invasive surgery. In his highly cited 2017 work, Khalid led a landmark retrospective cohort study of 110 patients treated with transoral robotic surgery (TORS). By applying the then-new eighth edition of the American Joint Committee on Cancer (AJCC) staging system to this cohort, his research provided essential clinical evidence demonstrating how the updated criteria more accurately stratify prognosis for HPV+OPC patients. This work has become a cornerstone for surgeons and oncologists, directly influencing how treatment outcomes are predicted and reported in the TORS era. With over 10 citations, this study underscores his role in bridging the gap between evolving staging guidelines and real-world surgical practice, cementing his reputation as a key contributor to precision staging in modern head and neck cancer care.

Research Focus

Key Achievements

1
H-Index
1
Papers
10
Total Citations
10
Avg Citations/Paper
🏆 Most Cited Paper
Application of the Eighth Edition <scp>A</scp>merican <scp>J</scp>oint <scp>C</scp>ommittee on <scp>C</scp>ancer Staging System for <scp>HPV</scp>‐Related Oropharyngeal Cancer Treated With Transoral Robotic Surgery
10 citations · 2017
📈 Most Prolific Year: 2017 (1 Papers)
🤝 Key Collaborators: 10
🏛 Institutions: Icahn School of Medicine at Mount Sinai

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago